Michael N. Mavros
Michael N. Mavros publishes mostly in Surgery, Epidemiology and Pulmonary and Respiratory Medicine, on topics such as Cholangiocarcinoma and Gallbladder Cancer Studies, Cardiac, Anesthesia and Surgical Outcomes and Hepatocellular Carcinoma Treatment and Prognosis.
- World rank
- #628,096 of 7,710,434 ranked researchers
- Rank in Greece
- #2,284 of 33,280
- Works
- 48
- Citations
- 3.1k
- Citations per work
- 64.6
What does Michael N. Mavros research?
Michael N. Mavros's work is mostly in Medicine (52%), Decision Sciences (4%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences2552.5%
- Medicine2552.5%
- Everything else2143.9%
- Social Sciences23.6%
- Decision Sciences23.6%
- 1Surgery30% of their works
- 2Epidemiology8% of their works
- 3Pulmonary and Respiratory Medicine7% of their works
- 4Cardiology and Cardiovascular Medicine4% of their works
- 5Statistics, Probability and Uncertainty4% of their works
- 6Infectious Diseases4% of their works
Research topics
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Cardiac, Anesthesia and Surgical Outcomes
- Hepatocellular Carcinoma Treatment and Prognosis
- Esophageal and GI Pathology
- Enhanced Recovery After Surgery
- Bacterial Identification and Susceptibility Testing
- Antibiotic Resistance in Bacteria
- Antimicrobial Resistance in Staphylococcus
Which keywords describe Michael N. Mavros's research?
The keywords of their largest research topics: Epidemiology, Biliary Tract Cancer, Cholangiocarcinoma, Cardiac Risk, Hepatocellular Carcinoma, Liver Cancer, Perioperative and Endoscopic Stenting.
- Multidrug-Resistant Bacteria
- Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry
- Antibiotic Resistance
- Esophageal Perforation
- Endoscopic Stenting
- Liver Cancer
- Cardiac Risk
- Biliary Tract Cancer
- Epidemiology
- Cholangiocarcinoma
- Hepatocellular Carcinoma
- Perioperative
- Enhanced Recovery
- Surgical Care
- MRSA
- Microorganism Identification
- Staphylococcus aureus
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 17 words, with their numbers
- Epidemiology92 topics
- Biliary Tract Cancer61 topic
- Cholangiocarcinoma61 topic
- Cardiac Risk51 topic
- Hepatocellular Carcinoma51 topic
- Liver Cancer51 topic
- Perioperative51 topic
- Endoscopic Stenting41 topic
- Enhanced Recovery41 topic
- Esophageal Perforation41 topic
- Surgical Care41 topic
- Antibiotic Resistance31 topic
- MRSA31 topic
- Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry31 topic
- Microorganism Identification31 topic
- Multidrug-Resistant Bacteria31 topic
- Staphylococcus aureus31 topic
Where does Michael N. Mavros work?
Michael N. Mavros's main affiliation in the publication record is Alfa Institute of Biomedical Sciences, Greece.
How many publications and citations does Michael N. Mavros have?
OpenAlex counts 48 works and 3,102 citations for Michael N. Mavros, an h-index of 25, ranking #628,096 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Michael N. Mavros. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.